Santen Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Santen Pharmaceutical has a total shareholder equity of ¥298.0B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥427.8B and ¥129.8B respectively. Santen Pharmaceutical's EBIT is ¥81.6B making its interest coverage ratio -124.2. It has cash and short-term investments of ¥83.4B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | -124.2x |
Cash | JP¥83.36b |
Equity | JP¥297.98b |
Total liabilities | JP¥129.84b |
Total assets | JP¥427.82b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4536's short term assets (¥224.6B) exceed its short term liabilities (¥91.4B).
Long Term Liabilities: 4536's short term assets (¥224.6B) exceed its long term liabilities (¥38.4B).
Debt to Equity History and Analysis
Debt Level: 4536 is debt free.
Reducing Debt: 4536 had no debt 5 years ago.
Debt Coverage: 4536 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4536 has no debt, therefore coverage of interest payments is not a concern.